Cumberland Pharmaceuticals Inc. (CPIX)

CPIX Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18.55	18.32	19.76	27.04	24.75	28.21
Cash & Cash Equivalents	18.55	18.32	19.76	27.04	24.75	28.21
Cash Growth	13.20%	-7.27%	-26.93%	9.24%	-12.26%	-22.13%
Receivables	10.65	9.76	13.16	6.88	12.38	7.86
Inventory	17.24	17.41	17.39	17.48	22.29	24.43
Other Current Assets	-10.23	-9.78	-4.44	-5.71	-9.46	-10.33
Total Current Assets	36.21	35.71	45.87	45.69	49.97	50.16
Property, Plant & Equipment	6.89	7.04	5.5	1.47	2.6	3.71
Goodwill and Intangibles	22.44	23.52	31.5	24.84	29	31.8
Other Long-Term Assets	15.98	15.5	10.05	12.47	14.89	18.88
Total Long-Term Assets	45.3	46.06	47.05	38.77	46.49	54.39
Total Assets	81.51	81.78	92.93	84.46	96.46	104.55
Accounts Payable	13.08	14.04	10.82	9.64	13.4	9.99
Current Debt	0.36	0.35	0.17	0.97	1.02	0.92
Other Current Liabilities	12.99	13.6	17.59	8.67	11.25	13.24
Total Current Liabilities	26.43	27.98	28.58	19.28	25.67	24.15
Long-Term Debt	21.28	18.08	20.79	15.09	16.06	20.58
Other Long-Term Liabilities	6.61	6.45	7.59	7.49	7.86	8.74
Total Long-Term Liabilities	27.89	24.53	28.37	22.58	23.92	29.31
Total Liabilities	54.32	52.52	56.95	41.86	49.59	53.46
Total Debt	21.65	18.43	20.96	16.06	17.08	21.5
Debt Growth	4.17%	-12.07%	30.51%	-5.95%	-20.56%	7.48%
Retained Earnings	-19.43	-17.49	-11.21	-5.64	-2.13	1.21
Shareholders' Equity	27.49	29.6	36.27	42.81	46.99	51.12
Net Cash / Debt	-3.1	-0.11	-1.2	10.98	7.68	6.72
Net Cash / Debt Growth	-	-	-	43.03%	14.32%	-58.62%
Net Cash Per Share	-0.22	-0.01	-0.08	0.74	0.51	0.44
Working Capital	9.78	7.73	17.29	26.41	24.3	26.01
Book Value Per Share	1.95	2.07	2.49	2.87	3.10	3.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).